Misoprostol

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

What providers need to know for counseling patients and managing their pain during IUD insertion.

A systemic review of “no-test” medication abortion, using an allis clamp during IUD placement, a trial of gabapentin for pain management during second-trimester abortions, and at-home urine pregnancy testing for follow-up of immediate management of an undesired pregnancy of unknown location.

Health care provider misconceptions about birth control as an abortifacient, a comprehension study of an over-the-counter combination birth control pill label, an updated Consensus from ACOG on menstrual suppression, and the effect of state-level abortion restrictions on early pregnancy loss management.

Trends in bHCG levels after medication abortion, a novel implant removal device, trends in IUD self-removal during the COVID-19 pandemic, and support for the patient-centeredness of telehealth birth control and abortion care.

Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.

Effective emergency contraception for individuals with obesity, the need for a reproductive justice lens in contraceptive counseling, a new treatment for bacterial vaginosis, and more.